ML-193

CAT: 0026-B3016-25Size: 25 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0026-B3016-25Size:25 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

ML-193 is a selective quinoline aryl sulfonamide antagonist for GPR55, a lysophosphatidylinositol (LPI)-sensitive receptor that is also involved in cannabinoid signaling. It inhibits GPR55 with an IC₅₀ of 221 nM. It also inhibits GPR55-dependent ERK phosphorylation with an IC₅₀ of 65 nM and blocks translocation of PKC βII. Pretreatment with ML-193 (1 μg/0.5 μl, 15 min before LPI), antagonized the LPI-induced nociception in a rat model.

Shipping Conditions

Storage Conditions

-20ºC

Shelf Life

36 months

Related Products

Catalog	Name
A1442-100	Anti-Blood Group Antigen A Antibody (CD173) (HE-193)
7264-50	SIRT1 (193-747 aa) (GST-tagged), Human recombinant
7264-25	SIRT1 (193-747 aa) (GST-tagged), Human recombinant
B1142-25	ML-240
B2730-1	ML-277
9448-10	ML-204
2763-5	ML-324
B2666-5	ML-216
B2605-5	ML-385
B2076-5	ML-365

Alternative Products

Catalog	Name
C4531-10	ML-193
NDB12180-01	ML 193
A22553-25	ML-193 25mg
A22553-5	ML-193 5mg
A22553-10	ML-193 10mg
A22553-100	ML-193 100mg
A22553-50	ML-193 50mg
A22553-10mM-D	ML-193 10mM * 1mL in DMSO
BDE19301ZT10	BDE 193 10ug/ml in Iso-octane
BDE1931ZT1	BDE 193 100ug/ml in Iso-octane

ML-193

Related Products

Alternative Products

Popular Products